Home Health Topics Health Reports Learning Centers Find a Dermatologist Medical Website Design

Investigational Treatment for Psoriasis

Experimental Drug for Psoriasis Shows Promise

November 29, 2010

Researchers have announced that a new investigational drug treatment for psoriasis, briakinumab, has been shown to be safe and effective in a series of phase III clinical trials, according to a recent statement from the manufacturer, Abbott Laboratories.

In one 52-week study involving 317 people with psoriasis, 82% of the participants taking briakinumab had at least a 75% or greater improvement in the severity of their psoriasis symptoms after 24 weeks they reported; 66% of them maintained that degree of improvement after a full year.

Three of the clinical trials compared the effects of briakinumab to psoriasis drugs like Enbrel® (etanercept) and methotrexate; in each case, superior results were achieved with briakinumab.

"We are pleased to see the strong effect of briakinumab for psoriasis," said Bruce Bebo, Ph.D., of the National Psoriasis Foundation in a news release. "Because the response to psoriasis treatments varies for individuals, it's important to have as many treatments options as possible, and briakinumab looks like it could be an important addition to the repertoire of psoriasis treatments."

Article Continues Below

Briakinumab is a biologic medication that targets proteins linked to inflammation. The most common side effects associated with briakinumab were infection, stuffy nose, headache, joint pain, high blood pressure and back pain.

Sources: Abbott Laboratories news release; and National Psoriasis Foundation news release

Physician-developed and -monitored.
Original Date of Publication: 29 Nov 2010
Reviewed by: the Editorial Staff at
Last Reviewed: 29 Nov 2010
Last Modified:06 Dec 2010

©, Inc. All Rights Reserved.

More on Psoriasis (13 of 19 articles)

Bullying & Psoriasis

Read More »

  • Turn Down the Thermostat to Burn Fat?
  • Sleep-Deprived Kids May Be at Risk for Childhood Obesity
  • Allegra Approved for Over-the-Counter Sales
  • Cognitive Behavioral Therapy Helps Prevent a Second Heart Attack
  • FDA Approves Vilazodone for Major Depression
  • Behavioral Therapy Effective Insomnia Treatment for Older People
  • Health Tips from TV's The Doctors
  • Can the Drug TXA Save Lives?
  • Statin Use for Prevention of Heart Disease Questioned
  • Study Identifies Avoidable Breast Cancer Risk Factors
  • Zolpidem Side Effects Include Imbalance, Cognitive Impairment
  • Finding the Right Breast Cancer Doctor Affects Treatment Outcomes
  • When Is it OK to Stop Breastfeeding Exclusively?
  • Barriers to Skin Cancer Screening Revealed
  • Therapy Helps with Incontinence after Prostatectomy, Study Finds
  • AHA Issues Call for Reduced Sodium in Diets
  • Study Finds NSAID Side Effects Troubling
  • Sedentary Lifestyle & Heart Disease Risk
  • Study about Truvada® for HIV/AIDS Prevention
  • FDA Limits Prescription Acetaminophen Dosage, Requires "Black Box" Warning



Alternative Medicine

Animal Health

Avian Flu







General Health


LGBT Health

Male Health

Mental Health





Pediatric Health





Senior Health

Sexual Health

Sleep Disorder




Women's Health

Remedy Health Media logo® | Intelecare® | | |
Diabetes Focus® | Remedy's Healthy Living™ | Remedy® | RemedyKids™ | RemedyMD™
© 2011 Remedy Health Media, LLC. All rights reserved.

This website is certified by Health On the Net Foundation. Click to verify.This site complies with the HONcode standard for trustworthy health information:
verify here.